Luminal A vs. Luminal B Breast Cancer: What You Need to Know About Treatment and Prognosis

Master regulators of luminal and basal subtypes of breast cancer - Archana Iyer - RECOMB/RSG 2014

The clinical impact of gene expression assays on early luminal breast cancer

Kathy S. Albain: Patients with luminal A and B / HER2 negative breast cancer

Luminal A vs. Luminal B Breast Cancer: Key Differences

Basics of Hereditary Breast Cancer

Advancing Our Understanding of Basal-Like, Luminal A, and Luminal B Breast Cancers

Is breast cancer hereditary? Penn State Cancer Institute – Penn State Health

Highlights on omitting radiotherapy after surgery for luminal A Breast Cancer: The LUMINA Trial

Charles Perou - Keynote Breast Cancer Genomics and Genetics

Value of Hereditary Breast Cancer Testing

Updates in Genetic Testing and Breast Cancer

Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Breast Cancer

Understanding Breast Cancer

Gene expression profiling of breast cancer brain mets shows enrichment for non-luminal subtypes

Molecular Testing in Breast Cancer: Will it Become Standard Practice?

GRHL2 controlled gene expression networks in luminal breast cancer

Mutations and the Risk for Breast Cancer

Molecular Testing in Breast Cancer: Will it Become Standard Practice? - Kimberly Allison, MD

SuperPathway Analyses of Luminal and Basaloid Breast Cancers... - Christopher Benz